-
Three PK, Mirabellon will be the first imitation of Huadong Medicine
Time of Update: 2021-07-28
In October last year, Huadong Medicine reached a strategic cooperation and obtained the latter's Mirvetuximab Soravtansine's exclusive clinical development and commercialization rights in Mainland China, Hong Kong, Macau and Taiwan .
-
Hengrui's "Carrelizumab" new indication has been released!
Time of Update: 2021-07-28
The results of the study show that carrelizumab combined with chemotherapy for first-line treatment of patients with advanced or metastatic squamous non-small cell lung cancer can significantly prolong the progression-free survival of patients .
-
Ultra-thin spinal implants can help treat stubborn pain
Time of Update: 2021-07-28
According to a paper recently published in the journal "Science Advances", researchers at the University of Cambridge in the United Kingdom combined soft robotics manufacturing technology, ultra-thin electronics and microfluidic technology to develop an ultra-thin inflatable device that can treat the most severe limb pain , Such as leg and back pain that cannot be cured by painkillers, without the need for invasive surgery .
-
17 drug procurement catalogs are forbidden!
Time of Update: 2021-07-28
The drugs announced this time involve 17 specifications of 8 varieties, including recombinant human granulocyte stimulating factor injection, bacterial lysate capsule, Shengmai injection, amorolfine hydrochloride liniment, paroxetine hydrochloride enteric-coated sustained-release tablets, etc.
-
Hengrui Class 1 new drug is close to NDA, what signals have it released
Time of Update: 2021-07-28
Not long ago, the CDK4/6 inhibitor SHR6390 developed by Jiangsu Hengrui has been submitted to the domestic NDA for breast cancer; and 1 month ago, this product was also included in the breakthrough treatment program of CDE, and the indication was combined with fluorine.
-
Zhong Nanshan talks about mutant virus strains: the establishment of an immune barrier is imminent
Time of Update: 2021-07-28
"This time, due to the high viral load and highly infectious characteristics of the delta strain, as long as the patient was in the same space, unit, and building 4 days before the onset of illness, they were considered close contacts .
-
The price fight is tragic!
Time of Update: 2021-07-28
In this centralized procurement, 3 billion large varieties of oxaliplatin injection (50 mg/bottle) were selected in the bidding for 4 companies, namely Hengrui (91.
For example, Kelun Pharmaceutical, the main injection company, has selected all of the 11 centralized procurement products this time .
-
31 new confirmed cases and 5 local cases were confirmed on July 18
Time of Update: 2021-07-28
As of 24:00 on July 18, according to reports from 31 provinces (autonomous regions and municipalities) and the Xinjiang Production and Construction Corps, there are currently 565 confirmed cases (including 13 severe cases), 87,076 cured and discharged cases, and 4,636 deaths.
-
China Resources Shuanghe Irbesartan Dispersible Tablets are the first to pass the quality and efficacy consistency evaluation of generic drugs
Time of Update: 2021-07-28
Combining medical and urban retail data, Shuanghe Limin irbesartan dispersible tablets accounted for 3.
-
The adjustment of the medical insurance catalogue starts!
Time of Update: 2021-07-28
In the expert review stage, the National Medical Insurance Bureau will demonstrate the expert opinions of the professional group, and finally determine the list of drugs in five aspects: direct transfer, negotiation transfer, direct transfer, can transfer, and adjust the limited payment scope .
-
Analyze the key figures of the 2020 National Adverse Drug Reaction Monitoring Annual Report
Time of Update: 2021-07-28
In 2020, 1251 copies were received, an increase of 11% compared with 2019 (1130 copies), as shown in the figure below: ►Adverse drug reaction/event report ratio at county level The proportion of county-level reports on adverse drug reactions/events is one of the important indicators to measure the balanced development and coverage of my country’s adverse drug reaction monitoring work.
-
A total of 178,503,429 confirmed cases of new crowns worldwide
Time of Update: 2021-07-28
WHO: The global cumulative number of confirmed cases of new crown reached 178,503,429 WHO: The cumulative number of confirmed cases of COVID-19 worldwide reaches 178,503,429 WHO: Th
-
New research: mRNA COVID-19 vaccine can induce long-lasting immune response
Time of Update: 2021-07-28
A study published online a few days ago on the website of the British journal Nature showed that nearly 4 months after the first dose of vaccination, the immune response induced by the mRNA (messenger ribonucleic acid) new crown vaccine is still active .
-
Scientists analyze the relationship between silicone implants and the immune system
Time of Update: 2021-07-28
Choose carefullyChoose carefully After the animal experiments, the researchers analyzed a large number of cancer tissue samples from MD Anderson Cancer Center to study the human body's response to different types of silicone breast implants .
-
How to do drug immunogenicity research in the new registration era?
Time of Update: 2021-07-28
Immunogenic drugs may induce harmful immune responses in the body, and can form anti-drug antibodies and neutralizing antibodies.
-
The new crown variant strain delta has spread to 92 countries and the vaccine is still effective
Time of Update: 2021-07-28
Although a recent study published in The Lancet showed that against the Delta strain, the titers of neutralizing antibodies produced by the human body after being vaccinated with the new crown vaccine have been reduced, but Van Kelkhover emphasized that the vaccine is effective for prevention.
-
Liao Fulong: Artemisinin research reflects the spirit of Chinese researchers
Time of Update: 2021-07-28
"The discovery of artemisinin reflects not only an original Chinese medicine in the international medical and health field, but also reflects the spiritual outlook of a generation of Chinese scientific researchers, that is, their responsibility and responsibility for national tasks .
-
The centralized procurement of injections is speeding up, and how much pressure is there for the provincial alliance and national procurement to cut prices?
Time of Update: 2021-07-28
From the perspective of the included varieties, according to the combing, there are 9 varieties of felodipine, torasemide, fluorouracil, ozagrel sodium, iron sucrose injection, lidocaine, calcitriol, tranexamic acid, and argatroban It is the first time to participate in provincial-level mass procurement, or it is expected to refresh the national lowest price of corresponding drugs .
-
British expert: China's high vaccination efficiency helps control the epidemic
Time of Update: 2021-07-28
Zou Tan Kish, Research Center for Future Vaccine Production at Imperial College London: Because there are too many links behind it, this is a huge chain where various things are combined to achieve the ultimate goal .
-
Choose more than 50 varieties!
Time of Update: 2021-07-28
It is worth noting that the "Notice of Xinjiang Leading Organization Inter-provincial Alliance Drug Centralized Procurement" issued by the Qinghai Provincial Medical Insurance Bureau a few days ago has been circulated in the industry, involving ten varieties, including amoxicillin and clavulanate potassium, aspirin, and C.